Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

ClinicalTrials.gov ID: NCT00124982

Public ClinicalTrials.gov record NCT00124982. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 1:10 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multi-Center, Open Label Study to Evaluate the Efficacy, Tolerability and Safety of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-Biologic DMARDs Who Have an Inadequate Response to Anti-TNF Therapy and Have Limited Therapeutic Options

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to summarize the safety and tolerability of abatacept during 6 months of combined treatment with one or more of the background non-biologic disease modifying anti-rheumatic drugs (DMARDs) approved for rheumatoid arthritis (RA) in subjects with active RA. Secondary objectives assessed the clinical efficacy of combination treatment, including disease activity, physical function, and quality of life outcomes.

Study identification

NCT ID
NCT00124982
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
1,286 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2005 (Type not available)
Primary completion
Aug 2009 (Actual)
Completion
Aug 2009 (Actual)
Last update posted
Feb 27, 2012

2005 – 2009

United States locations

U.S. sites
114
U.S. states
35
U.S. cities
114
Facility City State ZIP Site status
Local Institution Birmingham Alabama — —
Local Institution Huntsville Alabama — —
Local Institution Paradise Valley Arizona — —
Local Institution Peoria Arizona — —
Local Institution Tucson Arizona — —
Local Institution Long Beach California — —
Local Institution Palm Springs California — —
Local Institution Palo Alto California — —
Local Institution San Diego California — —
Local Institution Santa Monica California — —
Local Institution Colorado Springs Colorado — —
Local Institution Denver Colorado — —
Local Institution Danbury Connecticut — —
Local Institution Hamden Connecticut — —
Local Institution Trumbull Connecticut — —
Local Institution Washington D.C. District of Columbia — —
Local Institution Aventura Florida — —
Local Institution Clearwater Florida — —
Local Institution Fort Lauderdale Florida — —
Local Institution Jupiter Florida — —
Local Institution Largo Florida — —
Local Institution Sarasota Florida — —
Local Institution Atlanta Georgia — —
Local Institution Blue Ridge Georgia — —
Local Institution Macon Georgia — —
Local Institution Morton Grove Illinois — —
Local Institution Evansville Indiana — —
Local Institution Indianapolis Indiana — —
Local Institution Des Moines Iowa — —
Local Institution Kansas City Kansas — —
Local Institution Prairie Village Kansas — —
Local Institution Bowling Green Kentucky — —
Local Institution Louisville Kentucky — —
Local Institution New Orleans Louisiana — —
Local Institution Boston Massachusetts — —
Local Institution Peabody Massachusetts — —
Local Institution Springfield Massachusetts — —
Local Institution Worcester Massachusetts — —
Local Institution Ann Arbor Michigan — —
Local Institution East Lansing Michigan — —
Local Institution Grand Rapids Michigan — —
Local Institution Lansing Michigan — —
Local Institution Petockey Michigan — —
Local Institution Minneapolis Minnesota — —
Local Institution Saint Paul Minnesota — —
Local Institution Omaha Nebraska — —
Local Institution Las Vegas Nevada — —
Local Institution Lebanon New Hampshire — —
Local Institution Nashua New Hampshire — —
Local Institution Cherry Hill New Jersey — —
Local Institution Dover New Jersey — —
Local Institution Manalapan New Jersey — —
Local Institution New Brunswick New Jersey — —
Local Institution Somerset New Jersey — —
Local Institution Teaneck New Jersey — —
Local Institution Voorhees Township New Jersey — —
Local Institution Albany New York — —
Local Institution Brooklyn New York — —
Local Institution Hewlett New York — —
Local Institution Lake Success New York — —
Local Institution Mineola New York — —
Local Institution New York New York — —
Local Institution Olean New York — —
Local Institution Orchard Park New York — —
Local Institution Rochester New York — —
Local Institution Schenectady New York — —
Local Institution Smithtown New York — —
Local Institution Syracuse New York — —
Local Institution Asheville North Carolina — —
Local Institution Charlotte North Carolina — —
Local Institution Hickory North Carolina — —
Local Institution Wilmington North Carolina — —
Local Institution Bismarck North Dakota — —
Local Institution Akron Ohio — —
Local Institution Beachwood Ohio — —
Local Institution Cleveland Ohio — —
Local Institution Columbus Ohio — —
Local Institution Mayfield Village Ohio — —
Local Institution Youngstown Ohio — —
Local Institution Portland Oregon — —
Local Institution Bala-Cynwyd Pennsylvania — —
Local Institution Bethlehem Pennsylvania — —
Local Institution Camp Hill Pennsylvania — —
Local Institution Duncansville Pennsylvania — —
Local Institution Erie Pennsylvania — —
Local Institution Meadville Pennsylvania — —
Local Institution Philadelphia Pennsylvania — —
Local Institution Pittsburgh Pennsylvania — —
Local Institution West Reading Pennsylvania — —
Local Institution Wexford Pennsylvania — —
Local Institution Willow Grove Pennsylvania — —
Local Institution Providence Rhode Island — —
Local Institution Myrtle Beach South Carolina — —
Local Institution Simpsonville South Carolina — —
Local Institution Sioux Falls South Dakota — —
Local Institution Hixson Tennessee — —
Local Institution Knoxville Tennessee — —
Local Institution Austin Texas — —
Local Institution Corpus Christi Texas — —
Local Institution Dallas Texas — —
Local Institution Galveston Texas — —
Local Institution Houston Texas — —
Local Institution Lubbock Texas — —
Local Institution San Antonio Texas — —
Local Institution Sugarland Texas — —
Local Institution Burke Virginia — —
Local Institution Chesapeake Virginia — —
Local Institution Fairfax Virginia — —
Local Institution Salem Virginia — —
Local Institution Seattle Washington — —
Local Institution Vancouver Washington — —
Local Institution Glendale Wisconsin — —
Local Institution La Crosse Wisconsin — —
Local Institution Madison Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00124982, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2012 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00124982 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →